Intelligence

DDW CGT eBook
#Advanced Therapies #Cell and gene therapy #Cell therapy #Drug discovery #eBook #Gene therapy

Where next for cell & gene therapy?

This eBook, sponsored by Oxford Nanopore Technologies, explores the latest developments in advanced therapies, which treatments are securing industry investment, and the challenges and opportunities of a changing regulatory landscape.

#DDW eBooks #Intelligence

#Coiled Therapeutics #Drug discovery #Oncology #Precision medicine

Coiled Therapeutics completes transition to clinical-stage company

Coiled Therapeutics, previously Roquefort Therapeutics, has completed the acquisition of the exclusive worldwide licence to AO-252 and admitted its shares to trading on the AIM Market of the London Stock Exchange.  Admission follows a successful fundraise of £8.5 ($11.3) million through the issue of 85,000,000 New Ordinary… Read More

#Business & Investment #News #Start-up Zone

#Artificial intelligence (AI)

Guide: Advances in cancer research

This DDW guide explores the latest advancements in cancer research, including an overview of recent market developments, how to selectively degrade essential proteins, the potential of KRAS inhibitors and novel approaches to radiotherapy.      Sponsored by   Copyright 2022 Drug Discovery World. Read More

#DDW Guides

DDW Cancer Research Guide
#Cancer research #Guide #Oncology

Guide: Advances in cancer research

This DDW guide explores the latest advancements in cancer research, including an overview of recent market developments, how to selectively degrade essential proteins, the potential of KRAS inhibitors and novel approaches to radiotherapy.

#DDW eBooks #DDW Guides

#Antibody drug conjugate (ADC) #Biotherapeutics #Drug discovery #eBook

Advances in the analysis of next-generation biotherapeutics

Discover how to accelerate ADC development with clearer, faster characterisation of charge heterogeneity and size/purity. This eBook explains when to apply advanced icIEF and CE-SDS methods for ADCs and other novel biotherapeutics to accelerate development timelines. Learn: icIEF vs IEX for ADC charge profiles Protecting unstable ADCs with on-board mixing… Read More

#eBooks #Resources

#Cell Science

Whitepaper – A Practical Guide to Robust Bispecific Antibody Cell Line Development

Discover how ProBio accelerates bispecific antibody development with optimised cell line strategies. This guide highlights proven methods such as two-vector expression systems and NGS‑enabled clone selection to improve purity, productivity, and manufacturing robustness. You will learn: How to reduce bispecific antibody impurities through chain‑ratio optimisation Methods to enhance… Read More

#Whitepapers

siRNA
#Atrium Therapeutics #Cardiovascular disease #RNA #Start-ups

New launch Atrium will focus on RNA medicines for cardiomyopathy

Atrium Therapeutics has launched as a newly independent, publicly traded company developing RNA therapeutics for people living with rare, life-threatening genetic cardiomyopathies.   Atrium Therapeutics was established in connection with Avidity Biosciences’ acquisition by Novartis. The company is led by Kathleen Gallagher, President and Chief Executive Officer (CEO),… Read More

#Business & Investment #News #Start-up Zone